Research summary, original research, 2019

Lightweight Lead Aprons: The Emperor's New Clothes in the Angiography Suite?

Lu H, Boyd C, Dawson J. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 2019

Read the original paper

In plain language

In laboratory testing of 15 in-use lead and lead-free aprons from South Australian hospitals, many provided less shielding than labelled, back panels especially, and performance varied widely among garments with the same 0.5 mm rating.

At a glance

Type of study
Original research, Phantom or simulation study
Who was studied
Phantom or simulation (no people)
Size
n = 15 garments
Where
Australia
Summary based on
the abstract

What it found

  • Many garments provided less lead equivalence than the manufacturer claimed, especially back panels.

    Key figures: 47% of front panels; 90% of back panels

  • A substantial share of panels failed minimum IEC requirements for angiographic use.

    Key figures: 20% of front panels; 62% of back panels

  • Garments all labelled 0.5 mm lead equivalence varied widely in scatter attenuation.

    Key figures: 38 fold difference

  • Scatter transmission varied with tube voltage for most garments.

    Key figures: 56% of garments differed by at least 49%

  • Most garments failed to comply with labelling standards.

Limits to keep in mind

Small sample of 15 garments from four hospitals in one Australian state, tested with a Perspex phantom in a simulated suite; garment age and condition may have affected results, and no staff dose or health outcomes were measured.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.